D-dimer-to-platelet count ratio as a novel indicator for predicting prognosis in HBV-related decompensated cirrhosis

D-dimer-to-platelet count ratio as a novel indicator for predicting prognosis in HBV-related decompensated cirrhosis

Background: Hepatitis B virus-related decompensated cirrhosis (HBV-DC) is a critical illness with a low survival rate. Timely identification of prognostic indicators is crucial for risk stratification and personalized management of patients. The present study aimed to investigate the potential of th...

Full description

Bibliographic Details
Main Authors:	Xia He, QiuMing Ding
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Heliyon
Subjects:	D-dimer-to-platelet count ratio (DPR) Hepatitis B virus Decompensated cirrhosis Predictor
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024026161

Similar Items

Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis
by: Hideyuki Tamai, et al.
Published: (2020-08-01)

Platelets, mean platelet volume, lymphocytes, leukocytes, and ratios of them altered in patients with hepatitis B virus‐related decompensated cirrhosis
by: Changzhi Xu, et al.
Published: (2022-06-01)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
by: Mingyu Li, et al.
Published: (2023-01-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)

Diagnostic performance of platelet count/spleen diameter ratio to detect esophageal varices in patients with cirrhosis
by: Julián David Martínez-Marín, et al.
Published: (2021-05-01)

Prognostic nutritional index: A potential biomarker for predicting the prognosis of decompensated liver cirrhosis
by: Yanan Xie, et al.
Published: (2023-01-01)

Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days
by: Xiaomei Xu, et al.
Published: (2021-05-01)

The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
by: Bo Ma, et al.
Published: (2022-09-01)

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
by: Tongyu Wang, et al.
Published: (2022-10-01)

Evaluation of Aspartate Aminotransferase-to-Platelet Ratio Index as a Non-Invasive Marker for Liver Cirrhosis
by: Princi Jain, et al.
Published: (2015-11-01)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
by: M. Chris Runken, et al.
Published: (2019-07-01)

Impact of COVID-19 on Patients with Decompensated Liver Cirrhosis
by: Tudor Voicu Moga, et al.
Published: (2023-02-01)

Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
by: Daniela Matei, et al.
Published: (2021-08-01)

Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis
by: Pernille Just Vinholt, et al.
Published: (2018-07-01)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
by: Hao-dan Mao, et al.
Published: (2023-03-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
by: S N Batskikh, et al.
Published: (2018-11-01)

Evaluation of five lymphocyte-based scores for prediction of mortality in hepatitis B virus-associated decompensated cirrhosis
by: Ting Mao, et al.
Published: (2023-08-01)

A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis
by: Yanan Xie, et al.
Published: (2022-12-01)

Platelet Count/Spleen Thickness Ratio and the Risk of Variceal Bleeding in Cirrhosis With Esophagogastric Varices
by: Huimin Liu, et al.
Published: (2022-07-01)

Construction and evaluation of a nomogram prediction model for bacterial infection in patients with decompensated hepatitis C cirrhosis
by: XUE Linlin, et al.
Published: (2023-01-01)

Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis
by: Edward Kurnia Setiawan Limijadi, et al.
Published: (2016-05-01)

Decreased Platelet Aggregation in Patients with Decompensated Liver Cirrhosis and TIPS Implantation
by: Asala Nassar, et al.
Published: (2023-07-01)

Analysis of hope level and its influencing factors in patients with decompensated cirrhosis
by: Yuanyuan Zhang, et al.
Published: (2023-02-01)

Mean Platelet Volume/Platelet Count Ratio as a Predictor of Both Incidence and Prognosis of Acute Ischemic Stroke in Hemodialysis Patients
by: Ma L, et al.
Published: (2023-09-01)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
by: Manasa Kandula, et al.
Published: (2016-12-01)

Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy
by: Annie S. Hong, et al.
Published: (2022-06-01)

Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients
by: Francisco Barrera, et al.
Published: (2009-10-01)

ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis
by: Theodora Oikonomou, et al.
Published: (2019-01-01)

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis
by: JiHyun An, et al.
Published: (2022-09-01)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
by: Gemma Llibre-Nieto, et al.
Published: (2021-04-01)

Platelet count/splenic diameter ratio: Analysis of its capacity as a predictor of the existence of esophageal varices in liver cirrhosis
by: Natarajan M, et al.
Published: (2023-10-01)

Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study
by: Xu Huang, et al.
Published: (2022-11-01)

Plasma diamine oxidase level predicts 6-month readmission for patients with hepatitis B virus-related decompensated cirrhosis
by: Feng-Cai Li, et al.
Published: (2019-09-01)

A bite difficult to heal: Pasteurella multocida induced decompensated hepatic cirrhosis
by: Hiren Patel, et al.
Published: (2021-05-01)

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
by: Maria Tampaki, et al.
Published: (2023-02-01)

Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? – Treatment of Patients with Decompensated Cirrhosis
by: Geum-Youn Gwak
Published: (2016-03-01)

Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis
by: Jordan Sack, et al.
Published: (2017-01-01)

The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
by: Jung Hee Kim, et al.
Published: (2023-12-01)

Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701)
by: Qian Yu, et al.
Published: (2022-11-01)

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis
by: Chisato Saeki, et al.
Published: (2023-07-01)